LONDON, April 14, 2016 /PRNewswire/ --
Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injector & Autoinjectors, and Glass Pre-Filled Syringes
What can be expected from the pre-filled syringes market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects there.
Our 206-page report provides 123 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall regional market and national level. You will see financial results, an interview, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.
Forecasts from 2016-2026 and other analyses show you commercial prospects
Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and STEP analysis) and commercial developments.
See revenue forecasts for the leading submarkets and indications
How will submarkets perform to 2026? Our study forecasts revenues in the following national submarkets:
• National and Regional Markets
• Leading Therapeutic Sectors
• Leading Pre-Filled Device Therapies
• Pre-Filled Syringe and Related Technology Manufacturers
Leading companies and potential for market growth
Overall revenue for the Pre-filled syringe market will reach $6,940m in 2020, our work forecasts. We predict strong revenue growth through to 2026. A number of new injectable drugs and advances in technology are seen as factors driving growth over the forecast period.
Our work analyses the key companies in the market. See visiongain's analysis of 14 leading companies, including these:
• Becton, Dickinson and Company
• Gerresheimer
• Schott
• Baxter
• Nipro
• Weigao
• Unilife
• Roselabs
• SHL Group
• Ypsomed
• Haselmeier
• Owen Mumford
• Bespak
• Datwyler
A company profile gives you the following information where available:
• Discussion of a company's activities and outlook
• Company news relevant to the market
• Historical revenues
Discover capabilities, progress, and commercial prospects, helping you stay ahead.
What issues will affect the Pre-Filled Syringe industry?
Our new report discusses issues and events affecting the pre-filled syringe market. You will find discussions, including qualitative analyses on a range of topics.
You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.
How the Pre-Filled Syringes Market 2016-2026 report helps you
In summary, our 206-page report gives you the following knowledge:
• Revenue forecasts to 2026 for the Pre-Filled Syringes market - discover the industry's prospects, finding promising places for investments and revenues
• Revenue forecasts to 2026 for the leading national markets - US, Japan, EU5, BRIC
• Revenue forecasts to 2026 for submarkets - discover prospects for leading therapeutic areas, as well as products within these areas. Identify the key trends driving and restraining growth in the market, including government policy and economic conditions relevant to the market.
• Assessment of 14 leading companies - historical revenue, news and upcoming product releases
• Discussion of what stimulates and restrains the market
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain's study is for everybody needing commercial analyses for the pre-filled syringes market and leading companies. You will find data, trends and predictions. Please order our report now.
Companies Mentioned in the Report
Abbvie
Ache
Amega Biotech
Amgen
Antares Pharma
Aptar Stelmi
AstraZeneca
Baxter International
Becton, Dickinson and Company
Bespak
Biocon
Bioject Medical Technologies
Biomarin
Biosidus
Boehringer Ingelheim
Bristol-Myers Squibb
Cambridge Consultants
CareFusion Corporation
Celgene
Centocor
Daikyo Seiko
Datwyler
Dong-A
Dr. Reddy's
Eisai Pharmaceutical
Eli Lilly
Ferring
Gan & Lee
GeneScience Pharmaceuticals
Gerresheimer
GlaxoSmithKline
Haselmeier
Helvoet Pharmaceutical
Hospira
Incepta Pharmaceuticals
Janssen Biotech
Johnson and Johnson
LG Life Sciences/Biopartners
Mannkind
Merck & Co
Merck Serono
Mitsubishi Tanabe
Nektar Therapeutics
Nipro
Novartis
Novo Nordisk
OPKO Health
Oval Medical
Owen Mumford
PA Consulting Group
Palatin Technologies
Pfizer
PharmaJet
Pharmstandard
Polfa Tarchomin
Regeneron
Rhone Poulenc-Rorer
Roehr Products
Roselabs Bioscience
Samsung Bioepis
Sandoz
Sanofi
Schott
Schott Kaisha
Schott Xinkang Pharmaceutical Packaging
SciGen
Shanghai Celgen Bio-Pharmaceutical
Shanghai CP Guojin
SHL Group
Square Pharmaceuticals
Stevanato Group (Ompi)
Takeda Pharmaceutical
Terumo
Teva Pharmaceutical
Tonghua Dongbao
UCB
Unlife
Vetter
Vetter Pharma
Weigao
West Pharmaceuticals
Wockhardt
Ypsomed
Zeon
Organisations Mentioned in the Report
Battele Memorial Institute
Carl Zeiss Foundation
Centers for Disease Control (US)
European Society of Cardiology
National Health Service (UK)
Parenteral Drug Association
PATH
UNICEF
US Agency for International Development
US Federal Drug Administration
World Health Organization
To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com
To request an exec summary of this report please email Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44(0)20-7336-6100
Or click on https://www.visiongain.com/Report/1613/Pre-Filled-Syringes-Market-Forecast-2016-2026
Share this article